Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".

Gomez, Jorge A; Guevara, Javier Nieto; Carlos, Josefina C; de Castro, Joanne A; Josue, Donald Ray; Rodriguez, Edwin

Gomez, Jorge A; Guevara, Javier Nieto; Carlos, Josefina C; de Castro, Joanne A; Josue, Donald Ray; Rodriguez, Edwin.

Afiliação

Gomez JA; GlaxoSmithKline, Buenos Aires, Argentina. jorge.a.gomez-@gsk.com.
Guevara JN; GlaxoSmithKline, Panama City, Panama.
Carlos JC; University of the East-Ramon Magsaysay Memorial Medical Center Incorporated, Manila, Philippines.
de Castro JA; Department of Pediatrics, De La Salle Health Sciences Institute, Cavite, Philippines.
Josue DR; GlaxoSmithKline, Taguig, Philippines.
Rodriguez E; GlaxoSmithKline, Taguig, Philippines.

Infect Dis Ther ; 11(4): 1757-1761, 2022 Aug.

Article em En | MEDLINE | ID: mdl-35575972

Palavras-chave

Costbenefit analysis; Immunization; Pediatric; Philippines; Pneumococcal conjugate vaccine; Pneumococcal disease; Pneumonia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Infect Dis Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Argentina País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google